Scinai Immunotherapeutics Ltd. American Depositary Shares

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCNI and other ETFs, options, and stocks.

About SCNI

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman
CEOAmir Reichman
Employees
31
Employees31
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
31
Employees31

SCNI Key Statistics

Market cap
486.21K
Market cap486.21K
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
16.81K
Average volume16.81K
High today
$0.57
High today$0.57
Low today
$0.5501
Low today$0.5501
Open price
$0.5501
Open price$0.5501
Volume
3.08K
Volume3.08K
52 Week high
$6.18
52 Week high$6.18
52 Week low
$0.55
52 Week low$0.55

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.